AI assistant
Sending…
AbbVie Inc. — Director's Dealing 2014
Mar 4, 2014
29755_dirs_2014-03-04_c18b386b-2db6-4e34-93c8-8e82f39d2a0d.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: AbbVie Inc. (ABBV)
CIK: 0001551152
Period of Report: 2014-02-28
Reporting Person: GONZALEZ RICHARD A (Chairman of the Board and CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2014-02-28 | Common stock, $0.01 par value | F | 46811 | $50.91 | Disposed | 400202 | Direct |
| 2014-03-04 | Common stock, $0.01 par value | S | 269 | $51.19 | Disposed | 399933 | Direct |
| 2014-03-04 | Common stock, $0.01 par value | S | 1800 | $51.1960 | Disposed | 398133 | Direct |
| 2014-03-04 | Common stock, $0.01 par value | S | 2230 | $51.20 | Disposed | 395903 | Direct |
| 2014-03-04 | Common stock, $0.01 par value | S | 500 | $51.2140 | Disposed | 395403 | Direct |
More from AbbVie Inc.
Regulatory Filings
2026
Jun 1
Declaration of Voting Results & Voting Rights Announcements
2026
May 12
Interim / Quarterly Report
2026
May 8
Regulatory Filings
2026
Apr 29
Capital/Financing Update
2026
Apr 3
Major Shareholding Notification
2026
Mar 26
Proxy Solicitation & Information Statement
2026
Mar 23
Proxy Solicitation & Information Statement
2026
Mar 23
Capital/Financing Update
2026
Mar 4
Director's Dealing
2026
Mar 4